Handbook of Clinical medicine

and Gram Ωve includ- Dose adjust in liver dysfunction. ing -lactam-resistant strains. SEs: N&V, photosensitivity, LFTs. Other Clindamycin Gram +ve cocci (not enterococci),  risk C. diffi cile. MRSA, anaerobes. Linezolid Gram +ve cocci, MRSA, VRE, MAOI: check interactions, myelo- anaerobes, mycobacteria. suppression, optic neuropathy. Chloramphenicol Gram +ve, Gram Ωve, anaerobes, Systemic use limited by myelo- mycoplasma, chlamydia, conjunc- suppression. tivitis (topical). Fusidic acid Staphylococci. SES: GI, LFTs. Table 9.8 Inhibitors of nucleic acid synthesis Antibiotic Indications Considerations Folate synthesis inhibitors Trimethoprim Gram Ωve: UTI, prostatitis. Inhibits creatinine secretion: serum creatinine without GFR. Co-trimoxazole Pneumocystis jirovecii, GI Synergistic combination. Good (sulfamethoxa- infection (eg Shigella, E. coli), oral absorption and tissue/ zole + trimetho- protozoans (eg Cyclospora), CSF penetration. SEs: folate prim) listeria, nocardia, MRSA. defi ciency, K+, rash, myelosup- pression, haemolysis with G6PD defi ciency. Fluoroquinolones Ciprofl oxacin Broad including Pseudomonas: SEs: GI irritation, CNS eff ects ( Levofl oxacin UTI, prostatitis, atypical and seizure threshold, headache, hospital-acquired chest infection, drowsiness, mood change), pe- Moxifl oxacin infectious diarrhoea. ripheral neuropathy, tendinopa- thy (Achilles), QT, C. diffi cile. Others Metronidazole Anaerobic infection: intra-ab- Good oral absorption. Dose dominal, pelvic, oral, soft-tissue. adjust for liver function. SEs: Bacterial vaginosis. C. diffi cile.
